Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
2.120
-0.110 (-4.93%)
At close: Sep 18, 2026, 4:00 PM EDT
2.190
+0.070 (3.30%)
After-hours: Sep 18, 2026, 7:53 PM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $1.88 million as of September 18, 2026. Its market cap has decreased by -61.19% in one year.
Market Cap
1.88M
Enterprise Value
17.18M
1-Year Change
-61.19%
Ranking
Category
Stock Price
$2.12
ChartMarket Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $1.88M, a decrease of -96.09%. That is a compound annual growth rate of -48.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.88M | -48.62% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.22% |
| Dec 29, 2023 | 2.64M | -57.26% |
| Dec 30, 2022 | 6.17M | -83.58% |
| Dec 31, 2021 | 37.60M | -21.81% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 2.43M |
| Curis | 2.34M |
| Oragenics | 2.26M |
| Virax Biolabs Group | 1.98M |
| Tessera Defense and Homeland Security | 1.92M |
| Artelo Biosciences | 1.91M |
| Decoy Therapeutics | 1.89M |
| Silexion Therapeutics | 1.89M |